An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat
Authors:
- 31 July 2007
- journal article
- Published by Wiley in BJU International
- Vol. 100 (3) , 658-663
Abstract
OBJECTIVE: To present evidence that rats fed a high‐fat diet could serve as a useful animal model to study both lower urinary tract symptoms (LUTS) and erectile dysfunction (ED), as recent epidemiological studies have shown a strong association between LUTS and ED but the physiological basis behind this relationship is unknown. MATERIALS AND METHODS: In all, 24 male Sprague‐Dawley rats were divided into two groups: nine controls were fed a ‘normal’ diet and 15 were fed a high‐fat diet (hyperlipidaemic rats). After 6 months all the rats had bladder and erectile functions evaluated using awake cystometry and cavernosal nerve electrostimulation, respectively. After the functional studies were completed, the penis, prostate and bladder were collected for immunohistochemical analysis. RESULTS: The hyperlipidaemic rats had significantly higher serum cholesterol and low‐density lipoprotein than the controls ( P < 0.05). The hyperlipidaemic rats also had significantly worse erectile function ( P = 0.004) and developed more bladder overactivity ( P = 0.004) than the controls. In the hyperlipidaemic rats there was significant muscle hypertrophy in the peri‐urethral lobe of the prostate ( P < 0.001) and in the bladder ( P < 0.05). There was also greater P2X 1 (purinoceptor) staining as well as other molecular changes in the bladder of the hyperlipidaemic rats. CONCLUSIONS: In this hyperlipidaemic rat model three abnormalities were consistently detected: prostatic enlargement, bladder overactivity, and ED. This rat model could be a useful research tool for understanding the common causes of LUTS and ED, as well as facilitating the development of preventive measures and better therapies to treat both conditions.Keywords
This publication has 24 references indexed in Scilit:
- Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiologyBJU International, 2006
- Long‐term efficacy and safety of alfuzosin 10 mg once daily: a 2‐year experience in ‘real‐life’ practiceBJU International, 2006
- Incidence of Extragenital Vascular Disease in Patients With Erectile Dysfunction of Arterial OriginJournal of Urology, 2005
- OXIDATIVE STRESS IN ARTERIOGENIC ERECTILE DYSFUNCTION: PROPHYLACTIC ROLE OF ANTIOXIDANTSJournal of Urology, 2005
- Alterations in neurogenically mediated contractile responses of urinary bladder in rats with diabetesAmerican Journal of Physiology-Renal Physiology, 2005
- Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunctionBJU International, 2005
- Efficacy of extended‐release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunctionBJU International, 2004
- The Effect of Vascular Endothelial Growth Factor and Adeno-Associated Virus Mediated Brain Derived Neurotrophic Factor on Neurogenic and Vasculogenic Erectile Dysfunction Induced by HyperlipidemiaJournal of Urology, 2003
- Enhanced Force Generation by Corpus Cavernosum Smooth Muscle in Rabbits With Partial Bladder Outlet ObstructionJournal of Urology, 2002
- Enhanced Force Generation by Corpus Cavernosum Smooth Muscle in Rabbits With Partial Bladder Outlet ObstructionJournal of Urology, 2002